Emglif M 12.5/500mg Tablet – For Blood Sugar Control in Diabetes
Emglif M 12.5/500mg Tablet – For Blood Sugar Control in Diabetes
Emglif M 12.5/500mg Tablet – For Blood Sugar Control in Diabetes
Description
Emglif M 12.5/500mg Tablet (Empagliflozin + Metformin HCl)
Emglif M 12.5/500mg Tablet is a combination medicine containing empagliflozin and metformin hydrochloride, commonly prescribed in Pakistan for the management of type 2 diabetes. It works by improving the body’s response to insulin, reducing glucose production in the liver, and helping excess sugar leave the body through urine. This dual action helps maintain better blood sugar control in adults whose diabetes is not adequately managed with diet and exercise alone. Emglif M is usually recommended as part of long-term diabetes care under medical supervision to support stable glucose levels and overall metabolic health. Oxygen Pharmacy ensures this product is original and supplied through authorized pharmaceutical sources.
